Fasanello, Diana C.
Su, Jin
Deng, Siyu
Yin, Rose
Colville, Marshall J.
Berenson, Joshua M.
Kelly, Carolyn M.
Freer, Heather
Rollins, Alicia
Wagner, Bettina
Rivas, Felipe
Hall, Adam R.
Rahbar, Elaheh
DeAngelis, Paul L.
Paszek, Matthew J.
Reesink, Heidi L. http://orcid.org/0000-0001-8534-8839
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08AR068469)
Harry M. Zweig Memorial Fund for Equine Research
National Institutes of Health (R24 GM08291, R01 GM134226)
National Institute of Food and Agriculture (2015-67015-23072, 2019-67015-29833)
Article History
Received: 1 March 2021
Accepted: 22 July 2021
First Online: 20 August 2021
Declarations
:
: The Institutional Animal Care and Use Committee (IACUC) at Cornell University approved the animal studies with IACUC protocol numbers 2005-0151 and 2011-0027. Owner informed consent was obtained for all horses included in the study.
: Not applicable.
: Adam R. Hall, Elaheh Rahbar, and Paul L. DeAngelis are included as inventors on a patent describing SS-nanopore technology.